Erin Schenk, MD, PhD
Associate Dean, Medicine-Medical Oncology

Associate Professor of Medicine, Division of Medical Oncology
Clinic (720) 848-9264 (Lung Cancer Clinic)
Print Profile
Email Profile
Featured Provider Photo

Gender: Female
Languages: English
Department, Section/Division: Medicine-Medical Oncology

Practice Locations

UCHealth Lung Cancer Clinic - Anschutz Medical Campus
1665 Aurora Ct
Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-0300
More providers at this location

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Hematology, Board Certification (2018)
  • Internal Medicine - Medical Oncology, Board Certification (2018)
Conditions & Treatments
  • Cancers
  • Lung Cancer
Clinical Interest for Patients
Novel immune therapy based clinical trials for patients with lung cancer Multidisciplinary management of lung cancer

Care Philosophy
The diagnosis of lung cancer is life changing and the information can be overwhelming. As a specialist in Thoracic Oncology, my job is to provide the best possible, personalized care for my patients. The treatment options for lung cancer have dramatically increased in number, effectiveness, and tolerability. Starting patients on the right treatment for them is key to helping them do as well as possible. These options can include standard of care therapy - therapies that are available 'off the shelf' - or clinical trials. At the University of Colorado/UCH Lung Cancer Clinic, the care of patients with lung cancer is a multidisciplinary effort. Frequently, my patients see and are also treated by my colleagues who specialize in thoracic cancer including Thoracic Surgeons, Radiation Oncologists, and Pulmonologists. We work as a team to maximize treatment benefit for patients.

Public Speaking
Yes

Education & Training

Medical Schools:
  • MD, Mayo Medical School (2011)

Graduate Schools:
  • PhD, Mayo Graduate School (2011)

Residency Program:
  • College of Medicine, Mayo Clinic Program, Internal Medicine (2014)

Fellowships:
  • College of Medicine, Mayo Clinic (Rochester) Program, Hematology and Oncology (2018)

Recognition & Awards

  • Translational Research Scholar, School of Medicine, University of Colorado (2022)
    The Translational Research Scholar Program aims to foster translational research among the School’s early career faculty, facilitating the pursuit of new lines of exploration and elevating and expanding the scope of their translational research.
  • Member, ASCO Expert Panel Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations, ASCO (2022)
    https://ascopubs.org/doi/10.1200/JCO.22.02121
  • Member, ASCO Expert Panel Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations, ASCO (2022)
    https://ascopubs.org/doi/10.1200/JCO.22.02124
  • LUNGevity Career Development Award, LUNGevity (2021)
    This research grant provides significant funding for 3 years to promising early career investigators engaged in lung cancer research.
  • Paul Calabresi Career Development Award for Clinical Oncology K12, University of Colorado Cancer Center (2019)
  • Finalist, Immuno-Oncology Young Investigators' Forum (2018)
    Houston, TX
  • Outstanding Fellow Award, Highest Rated and Top Abstract, Minnesota Society of Clinical Oncology (2018)
    Minneapolis, MN
  • International Association for the Study of Lung Cancer (IASLC) Academy Award, IASLC (2018)
    Toronto, Canada
  • IASLC Academy Award, IASLC (2017)
    Yokohama, Japan

Professional Memberships

  • American Association for Cancer Research (AACR), Member
  • American Society of Clinical Oncology (ASCO), Member
  • IASLC, Member

Research & Grants

Grants
  • Translational Research Scholar Program (2022)
    School of Medicine, University of Colorado, $300000
  • LUNGevity Career Development Award (2021)
    LUNGevity, $100000
  • ACS-IRG Pilot Award (2020)
    American Cancer Society via CU Cancer Center, $30000
  • COE Pilot Grant - Personalized medicine models and linked electronic database to assess racial and socioeconomic disparities among patients with lung cancer in Colorado (2020)
    CU Cancer Center, $100000
  • The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer (2020)
    Cancer League of Colorado, $60000
  • Paul Calabresi Clinical Oncology Scholar (2019)
    NCI/NIH K12, $155040
Research interests for Patients:
My laboratory studies the lung cancer tumor microenvironment, a diverse collection of cell types that can be found in and around lung tumors. We are focused on the immune cells within the tumor and how specific subtypes can contribute to treatment resistance. Ultimately, we hope to use our findings to improve therapy for patients with lung cancer.

Information for Referring Providers


Clinic Phone: (720) 848-9264 (Lung Cancer Clinic)
Fax Phone: (720) 848-0360 (Lung Cancer Clinic Fax)